Healthcare Industry News: HSMN NewsFeed
News Release - October 4, 2017
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate SecretaryMARLBOROUGH, Mass., Oct. 4, 2017 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Desiree Ralls-Morrison as senior vice president, general counsel and corporate secretary. Ralls-Morrison will join Boston Scientific on November 30, 2017, as a member of the executive committee, with responsibility for providing legal counsel across the company's global businesses and functions, and overseeing the company's global compliance function.
Ralls-Morrison will succeed Timothy Pratt, executive vice president, general counsel and corporate secretary, who announced his intention to retire from the company in April 2017.
"Desiree is an accomplished leader in the healthcare industry with deep expertise in broad-ranging legal matters and enterprise business strategy," said Mike Mahoney, chairman and chief executive officer, Boston Scientific. "We look forward to her contributions to Boston Scientific and the company's continued growth."
Ralls-Morrison most recently held the role of senior vice president, general counsel, corporate secretary, and head of the global litigation, government affairs and public policy organizations at Boehringer Ingelheim USA. Previously, she was general counsel for the Johnson & Johnson consumer group, having progressed through roles of increasing responsibility including senior counsel, assistant general counsel, and vice president of law for the women's health, nutritionals and over the counter businesses.
Earlier in her career, Ralls-Morrison was a senior attorney and assistant counsel at Merck & Co, Inc., focusing largely on regulatory and product liability matters, and prior to that, she held litigation roles at the law firms of Kelley Drye & Warren LLP and Shipman & Goodmand LLP. She currently serves on the Danbury Hospital/New Milford Hospital Board of Directors and The Inner-City Foundation for Charity and Education. Desiree earned her juris doctor from Harvard Law School, and her bachelor of arts in economics and political science from Wesleyan University.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
Source: Boston Scientific
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsBoston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.
Boston Scientific Announces Positive Results from WHISPER Spinal Cord Stimulation Study
Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter(TM) Spinal Cord Stimulator System